|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
|
|---|---|---|---|
| Cash flows from operating activities: | |||
| Net increase (decrease) in net assets resulting from operations | |||
| Adjustments to reconcile net increase (decrease) in net assets resulting from operations to net cash provided by (used in) operating activities: | |||
| Net unrealized (appreciation) depreciation on investments | |||
| Non-controlled/Non-affiliated Investments | |||
| Total net unrealized (appreciation) depreciation on investments | |||
| Net change unrealized (appreciation) depreciation on investments | |||
| Non-controlled/Non-affiliated Investments | |||
| Controlled/affiliated Investments | |||
| Total net change unrealized (appreciation) depreciation on investments | |||
| Net change unrealized (appreciation) depreciation on derivative instruments | |||
| Net change unrealized (appreciation) depreciation on foreign currency and other transactions | |||
| Net realized (gain) loss on investments | |||
| Non-controlled/Non-affiliated Investments | |||
| Total net realized (gain) loss on investments | |||
| Net realized (gain) loss on derivative instruments | |||
| Net realized (gain) loss on foreign currency and other transactions | |||
| Payment-in-kind interest capitalized | |||
| Net accretion of discount and amortization of premium | |||
| Amortization of deferred financing costs | |||
| Amortization of offering costs | |||
| Purchases of investments | |||
| Cash settlement of derivatives | |||
| Proceeds from sale of investments and principal repayments | |||
| Changes in operating assets and liabilities: | |||
| Interest receivable | |||
| Deferred offering costs | |||
| Receivable for investments sold | |||
| Due from Advisor | |||
| Other assets | |||
| Payable for investments purchased | |||
| Due to Advisor and affiliates | |||
| Management fee payable | |||
| Income incentive fee payable | |||
| Capital gains incentive fee payable | |||
| Accrued capital gains incentive fee | |||
| Interest and credit facility fees payable | |||
| Accrued expenses and other liabilities | |||
| Net cash provided by (used in) operating activities | |||
| Cash flows from financing activities: | |||
| Proceeds from Secured Credit Facility | |||
| Repayment of Secured Credit Facility | |||
| Deferred financing cost paid | |||
| Dividends paid in cash | |||
| Distributions paid in cash | |||
| Deferred offering costs paid | |||
| Proceeds from issuance of common shares | |||
| Redemptions paid in cash | |||
| Net cash provided by (used in) financing activities | |||
| Net increase (decrease) in cash, cash equivalents and restricted cash | |||
| Cash, cash equivalents and restricted cash, beginning of period | |||
| Cash, cash equivalents and restricted cash, end of period | |||
| Supplemental information and non-cash activities: | |||
| Cash paid for interest | |||
| Restructuring of portfolio investments | |||
| Reinvestment of distributions | |||
| Distribution Payable | |||
| Accrued but unpaid deferred financing cost | |||
| Accrued but unpaid deferred offering cost |
Loading...